Suncoast Radiopharmacy Services Inc is categorized under Wholesale Pharmaceutical Products in Tampa, FL and active since 2007.
Suncoast Radiopharmacy Services Inc was established in 2007, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact John Gangemi at the company’s single location by writing to 3501 Riga Boulevard # 300, Tampa, Florida FL 33619 or by phoning (651) 633-2402. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Suncoast Radiopharmacy Services Inc |
Contact Person: | John Gangemi |
Address: | 3501 Riga Boulevard # 300, Tampa, Florida 33619 |
Phone Number: | (651) 633-2402 |
Annual Revenue (USD): | $2.500.000 to $4.999.999 |
Founded: | 2007 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Wholesale Pharmaceutical Products |
SIC Code: | 5122 |
NAICS Code: | 424210 |
Share This Business: |
Suncoast Radiopharmacy Services Inc was started in 2007 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact John Gangemi for inquiries that concern Suncoast Radiopharmacy Services Inc by calling the company number (651) 633-2402, as your correspondence is most welcome. Additionally, the physical location of the single location of Suncoast Radiopharmacy Services Inc can be found at the coordinates as well as the street address 3501 Riga Boulevard # 300 in Tampa, Florida 33619.
For its online presence, you may visit Suncoast Radiopharmacy Services Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.